Health ❯ Diabetes

Treatment Options

Medications Insulin Injectable Medications GLP-1 Medications GLP-1 Receptor Agonists Weight Loss Drugs Weight Management Drug Efficacy GLP-1 Agonists Dipeptidyl Peptidase-4 Inhibitors Oral Medications Semaglutide Medication Clinical Trials FDA Approval Insulin Therapy GLP-1 Drugs

Biomea Fusion Reports Positive 52-Week Phase II Results for Icovamenib in Diabetes

Company-presented ATTD findings will guide dosing decisions for follow-on Phase II trials targeting defined patient groups.

Lilly Signs Up to $1.12 Billion Gene-Editing Pact to Tackle Hearing Loss

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study